Table 3.
Sample size, n (%) |
FPR, % (95% CI) |
Sensitivity, % (95% CI) |
PPV, % (95% CI) |
NPV, % (95% CI) |
|
---|---|---|---|---|---|
qPLR < 4% | |||||
t0 | 710 (100) | 5 (3–7) | 31 (25–36) | 78 (70–86) | 70 (68–71) |
t24 | 677 (95) | 0 (0–1) | 26 (21–32) | 97 (92–100) | 71 (69–72) |
t48 | 540 (76) | 0 (0–1) | 21 (16–26) | 98 (93–100) | 65 (64–67) |
t72 | 298 (42) | 0 (0–0) | 8 (4–12) | 100 (100–100) | 43 (42–44) |
NPi ≤ 2 | |||||
t0 | 710 (100) | 0 (0–0) | 10 (6–13) | 100 (100–100) | 65 (64–66) |
t24 | 682 (96) | 0 (0–0) | 12 (8–17) | 100 (100–100) | 67 (66–67) |
t48 | 543 (76) | 0 (0–0) | 9 (5–13) | 100 (100–100) | 62 (61–63) |
t72 | 301 (42) | 0 (0–0) | 9 (5–13) | 100 (100–100) | 43 (42–44) |
NSE > 60 μg/L | |||||
48-h | 625 (88) | 2 (0–3) | 39 (33–46) | 95 (91–100) | 70 (67–72) |
48-h plasma NSE and pupillometry predicting outcome in unconscious patients, M < 3, at ≥ 72 h | |||||
NSE > 60 μg/L | 187 (26) | 0 (0–0) | 42 (35–51) | 100 (100–100) | 76 (70–82) |
NSE > 60 μg/L + qPLR < 4.0 | 187 (26) | 0 (0–0) | 55 (47–63) | 100 (100–100) | 73 (66–79) |
NSE > 60 μg/L + NPi ≤ 2.0 | 187 (26) | 0 (0–0) | 50 (42–58) | 100 (100–100) | 74 (68–81) |
48-h plasma NSE and pupillometry predicting outcome in unconscious patients, M < 3, at ≥ 72 h (with extracerebral causes of death excluded) | |||||
NSE > 60 μg/L | 172 (24) | 0 (0–0) | 45 (37–53) | 100 (100–100) | 76 (69–82) |
NSE > 60 μg/L + qPLR < 4.0 | 172 (24) | 0 (0–0) | 58 (50–67) | 100 (100–100) | 72 (65–79) |
NSE > 60 μg/L + NPi ≤ 2.0 | 172 (24) | 0 (0–0) | 51 (43–60) | 100 (100–100) | 75 (68–82) |
The prognostic probabilities of quantitative pupillometry thresholds, 48-h plasma neuron-specific enolase, and the combination in unconscious patients, M < 3, at ≥ 72 h, predicting unfavorable outcomes at follow-up
qPLR quantitatively assessed pupillary light reflex, NPi Neurological Pupil index, M Glasgow motor scale, FPR false-positive rate, PPV positive predictive value, NPV negative predictive value